Navigation Links
Echo Therapeutics Announces First Quarter 2012 Financial Results
Date:5/11/2012

ization."

First Quarter 2012 Financial ResultsEcho's net loss for the first quarter of 2012 was $3.0 million, or ($0.08) per share, compared to $6.6 million, or ($0.20) per share, for the first quarter of 2011.  Operating loss for the first quarter of 2012 was $3.2 million compared to $1.6 million for the first quarter of 2011.  Research and development expenses were $1.4 million for the first quarter of 2012 compared to $0.9 million in the prior year.  The increase in research and development expenses are primarily related to increased manufacturing, development and clinical expenses, as well as personnel costs.  General and administration expenses were $1.9 million for the first quarter of 2012 versus $0.9 million in the prior year.  The increase in general and administrative expenses was primarily due to increased personnel and facility costs, as well as legal and other Nasdaq and public company expenses. The Company reported a cash balance of approximately $5.9 million as of March 31, 2012.Cautionary Statement Regarding Forward Looking StatementsThe statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Echo's ongoing studies, including the safety and efficacy of Echo's Symphony tCGM and Prelude SkinPrep Systems, the failure of future development and preliminary marketing efforts related to Echo's Symphony tCGM and Prelude SkinPrep Systems, Echo's ability to secure additional commercial partnering arrangements, risks and uncertainties relating to Echo's and its partners' ability to develop, market and sell diagnostic and transdermal drug delivery products based on its sk
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
2. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
3. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
4. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
5. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
10. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
11. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Reportlinker.com announces that a new market ... Global Heart Valve Repair and Replacement Market ... About Heart Valve Repair and Replacement Heart ... control the flow of blood during the cardiac ... such as valvular stenosis, valvular insufficiency or regurgitation, ...
(Date:8/27/2014)... 2014 Reportlinker.com announces that a new market ... Baby Food Eastern Europe 2014 ... 2014" is a new report by ERC that analyzes ... Eastern Europe , key segments, features & developments, ... examines trends which are currently affecting the industry. Furthermore, ...
(Date:8/27/2014)... , Aug. 27, 2014 North American lighting leader ... R&D 100 Award for the new OSRAM ITOS ® ... white light module for microscopy, endoscopy and surgical head lamps ... significantly higher efficacy and lamp life. "We,re honored ... of the most innovative new technologies of the past year," ...
Breaking Medicine Technology:Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
... Aug. 23 Imagenetix, Inc. (OTC Bulletin Board: IAGX ... in July and the first half of August that it expects ... September 30, 2010, to be from $2.8 to $3.2 million, an ... fiscal 2011 and 47% to 68% compared to the second quarter ...
... EXTON, Pa., Aug. 23 Kensey Nash Corporation (Nasdaq: ... regenerative medicine for a wide range of medical procedures, today ... ended June 30, 2010.   Fourth Quarter ... $21.9 million for the quarter, exceeding the high end of ...
Cached Medicine Technology:Imagenetix, Inc. Provides Net Sales Guidance for the Second Quarter Fiscal 2011 2Imagenetix, Inc. Provides Net Sales Guidance for the Second Quarter Fiscal 2011 3Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 2Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 3Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 4Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 5Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 6Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 7Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 8Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 9Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 10Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 11Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 12Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 13Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 14
(Date:8/27/2014)... Three locations will each receive $100,000 in funding to ... and follow-up care for patients served by community health ... Colorectal Cancer Roundtable and is part of the group,s ... adults 50 and over receiving regular screening for colorectal ... a competitive process are: Port Royal, South Carolina; New ...
(Date:8/27/2014)... CarePoint Health is proud to ... has joined our network, CarePoint Health Medical Group. ... Oko, Dr. Yanina Meshko and Dr. Nana Yenukashvili ... experienced physicians comprise CarePoint Health Medical Group, a ... Hudson County, representing a wide range of specialties. ...
(Date:8/27/2014)... returning to school this month will be up to ... Jennifer Reich, a researcher at the University of Colorado ... be fully vaccinated depends on the class privilege of ... Immunization Information, three children per 1000 in the U.S. ... all children receiving vaccines later than recommended. The number ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Dr. Winifred ... , a leader in promoting better health outcomes through ... addition of Ms. Maura Connor to the executive team ... Editor-in-Chief, Ms. Connor will be responsible for providing innovation, ... digital products and content across all markets. , ...
(Date:8/27/2014)... jaundice: It,s one of the last things a parent ... condition in babies less than a week old. , ... that a newborn is jaundiced and isn,t adequately eliminating ... to see, and severe jaundice left untreated can harm ... have developed a smartphone application that checks for jaundice ...
Breaking Medicine News(10 mins):Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 2Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 3Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 2Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 3Health News:Expression of privilege in vaccine refusal 2Health News:Maura Connor Joins Hayes, Inc. as Vice President, Digital Publishing, Editor-in-Chief 2Health News:New smartphone app can detect newborn jaundice in minutes 2Health News:New smartphone app can detect newborn jaundice in minutes 3
... A daytime sleep could have cardiovascular benefits according to new ... College in Pennsylvania in the US. Their study, looking at ... a stress test, found that those participants who slept for ... blood pressure after psychological stress than those who did not ...
... U.S. Department of Energy,s (DOE) Brookhaven National Laboratory reveals a ... overeat, or binge: In binge eaters but not ordinary obese ... a spike in dopamine - a brain chemical linked to ... 24, 2011, in the journal Obesity - suggest ...
... The University of Miami,s College of Arts and ... awarded a Howard Hughes Medical Institute grant to ... in response to the 2009 American Association of ... Future Physicians (SFFP)" report. The grant will ...
... scientists from the Swedish medical university Karolinska Institutet. A new ... that free radicals act as signal substances that cause the ... are molecules that react readily with other substances in the ... certain circumstances, through the damage caused to cells. Free radicals ...
... , SUNDAY, Feb. 27 (HealthDay News) -- A ... initially thought to dramatically cut the risk of several major ... of vitamin D by adults in the range of 4,000-8,000 ... metabolites in the range needed to reduce by about half ...
... BOSTON, Feb. 28, 2011 A gel developed to protect ... when used in the rectum, according to an early-phase study ... Infections (CROI). The results, based on rectal tissue biopsies sampled ... for one week, provide the first-ever evidence that tenofovir gel ...
Cached Medicine News:Health News:Blood pressure management: Sleep on it 2Health News:Binge eaters' dopamine levels spike at sight, smell of food 2Health News:Binge eaters' dopamine levels spike at sight, smell of food 3Health News:University of Miami awarded Howard Hughes Medical Institute experiment grant 2Health News:Free radicals may be good for you 2Health News: Higher Vitamin D Intake Could Cut Cancer Risk 2Health News:Tenofovir gel provides high level of protection against HIV in rectal tissue 2Health News:Tenofovir gel provides high level of protection against HIV in rectal tissue 3Health News:Tenofovir gel provides high level of protection against HIV in rectal tissue 4
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
A unique system for secure fixation of the cranial bone flap after craniotomy. Craniofix eliminates the need for mini plates, screws, and additional drills....
1.0 mm Micro System. The Titanium Micro System is also useful in the practice of ENT, Neurosurgery and Handsurgery....
... Cable System, designed for ... sublaminar interspinous fixation, non-displaced ... sternotomy closure. Consists of ... complete set of instruments ...
Medicine Products: